|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Regeneron Pharmaceuticals (NASDAQ: REGN) through any online brokerage.
The latest price target for Regeneron Pharmaceuticals (NASDAQ: REGN) was reported by HC Wainwright & Co. on October 22, 2021. The analyst firm set a price target for 842.00 expecting REGN to rise to within 12 months (a possible 47.11% upside). 30 analyst firms have reported ratings in the last year.
The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $572.36 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 4, 2021.
There is no upcoming split for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.